| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.008 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |